A detailed history of Exane Derivatives transactions in Cooper Companies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 9 shares of COO stock, worth $868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Previous 63 85.71%
Holding current value
$868
Previous $26,000 92.31%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$301.4 - $428.42 $16,275 - $23,134
-54 Reduced 85.71%
9 $2,000
Q1 2022

Apr 22, 2022

SELL
$379.46 - $424.54 $1,897 - $2,122
-5 Reduced 7.35%
63 $26,000
Q4 2021

Jan 28, 2022

SELL
$373.53 - $434.12 $75,826 - $88,126
-203 Reduced 74.91%
68 $28,000
Q3 2021

Oct 26, 2021

SELL
$396.76 - $455.92 $32,534 - $37,385
-82 Reduced 23.23%
271 $112,000
Q2 2021

Jul 28, 2021

SELL
$372.36 - $412.07 $53,992 - $59,750
-145 Reduced 29.12%
353 $139,000
Q1 2021

Apr 30, 2021

SELL
$357.26 - $392.57 $108,607 - $119,341
-304 Reduced 37.91%
498 $191,000
Q4 2020

Jan 27, 2021

SELL
$319.05 - $363.32 $243,435 - $277,213
-763 Reduced 48.75%
802 $291,000
Q3 2020

Oct 06, 2020

BUY
$280.08 - $347.78 $10,362 - $12,867
37 Added 2.42%
1,565 $527,000
Q2 2020

Jul 10, 2020

BUY
$270.93 - $320.3 $347,603 - $410,944
1,283 Added 523.67%
1,528 $433,000
Q1 2020

Apr 17, 2020

SELL
$243.44 - $359.98 $8,276 - $12,239
-34 Reduced 12.19%
245 $67,000
Q3 2019

Oct 15, 2019

BUY
$294.25 - $341.49 $82,095 - $95,275
279 New
279 $82,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.76B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.